Article Details
Retrieved on: 2021-01-05 13:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
This technology allows for the site-specific attachment of small molecule drugs to monoclonal antibodies. NBE-Therapeutics' next-generation ADCs ...
Article found on: www.onclive.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here